AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) weakened on stock markets Wednesday morning after the company and EUSA Pharma disclosed that EUSA Pharma has opted into the Phase 1/2 TiNivo study. The TiNivo trial is a Phase 1/2 …
AVEO Pharmaceuticals, Inc. AVEO was a big mover last session, as the company saw its shares rise around 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues …
Aveo raised $53 million in a public offering of its stock in January 2013 but did not disclose to investors the “critical fact” that the FDA, in 2012, recommended a second clinical trial, the SEC said. The FDA, which regulates drugs, was …
The sour note took another bite out of Aveo's stock price ($AVEO), with shares sliding 18% on the news. Over the last few weeks the stock has plummeted 67% as class action lawsuits piled up at the biotech's front office. A number of …
Aveo's stock price tumbled about 11 per cent to a near-two-year low on Monday after media reports emerged about Aveo's fees, in particular exit fees ranging from 20 to 40 per cent of the entry price residents' paid for the unit. Aveo gained …
On top of our midday losers list is AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). The healthcare stock dipped -12.50% to $1.64 after the company informed that its lead experimental drug Tivozanib was unlikely to succeed in a mid-stage …
we will take the opportunity to buy the stock back,’’ Mr Grady said. Aveo shares fell 34c to $2.71 on Monday, against NTA of $3.23. They rose 2c yesterday to $2.73. Mr Grady said he did not ­believe the reports were fair. “It did not have any of …
A year ago, they were trading at 61 cents. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVEO
If you want a Stock Review on ATHX, AVEO, BDSI, or BLRX then come over to http://dailystocktracker.com/register/ …